Radiation dosimetry of the α4β2 nicotinic receptor ligand (+)-[18F]flubatine, comparing preclinical PET/MRI and PET/CT to first-in-human PET/CT results

MLA

Mathias Kranz, et al. “Radiation Dosimetry of the Α4β2 Nicotinic Receptor Ligand (+)-[18F]Flubatine, Comparing Preclinical PET/MRI and PET/CT to First-in-Human PET/CT Results.” EJNMMI Physics, vol. 3, no. 1, Oct. 2016, pp. 1–17. EBSCOhost, https://doi.org/10.1186/s40658-016-0160-5.

APA

Mathias Kranz, Bernhard Sattler, Solveig Tiepolt, Stephan Wilke, Winnie Deuther-Conrad, Cornelius K. Donat, Steffen Fischer, Marianne Patt, Andreas Schildan, Jörg Patt, René Smits, Alexander Hoepping, Jörg Steinbach, Osama Sabri, & Peter Brust. (2016). Radiation dosimetry of the α4β2 nicotinic receptor ligand (+)-[18F]flubatine, comparing preclinical PET/MRI and PET/CT to first-in-human PET/CT results. EJNMMI Physics, 3(1), 1–17. https://doi.org/10.1186/s40658-016-0160-5

Chicago

Mathias Kranz, Bernhard Sattler, Solveig Tiepolt, Stephan Wilke, Winnie Deuther-Conrad, Cornelius K. Donat, Steffen Fischer, et al. 2016. “Radiation Dosimetry of the Α4β2 Nicotinic Receptor Ligand (+)-[18F]Flubatine, Comparing Preclinical PET/MRI and PET/CT to First-in-Human PET/CT Results.” EJNMMI Physics 3 (1): 1–17. doi:10.1186/s40658-016-0160-5.